Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus

QJM: An International Journal of Medicine

Volumn 99, Issue 12, 2006, Pages 871-876

  West, J ^a   Brousil, J ^a   Gazis, A ^b   Jackson, L ^a   Mansell, P ^b   Bennett, A ^a   Aithal, Guru P ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GLITAZONE DERIVATIVE; INSULIN; METFORMIN;

ADOLESCENT; ADULT; AGED; AGING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 33845876929     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcl116     Document Type: Article

References (20)

1. Marchesini G, Brizi M, Morselli-Labate A, Blanchi G, Bugianesi E, McCullogh A, Forlani G, Melachionda N. Association of non-alcoholic fatty liver disease and insulin resistance. Am J Med 1999; 107:450-5.
2. Matteoni C, Younossi Z, Gramlich T, Bopari N, Liu Y, McCullough N. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116:1413-19.
3. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126:460-8.
4. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study. Gut 2005; 54:533-9.
5. Shahib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study. Gastroenterology 2005; 128:620-6.
6. De Marco R, Locatelli F, Zoppini G. Cause-specific mortality in type 2 diabetes. Diabetes Care 1999; 22:756-61.
7. Trombetta M, Spiazzi G, Zoppini G, Muggeo M. Review article: Type 2 diabetes and chronic liver disease in the Verona diabetes study. Aliment Pharmacol Ther 2005; 22:24-7.
8. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh II. Normal serum aminotransferase concentration and risk of mortality from liver diseases: Prospective cohort study. Br Med J 2004; 328:983-7.
9. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986; 21:109-13.
10. Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 2001; 35:195-9.
11. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999; 94:3010-14.
12. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum aminotransferase activity in the United States. Gastroenterology 2003; 124:71-9.
13. Diehl AM, Clark JM. Defining non-alcoholic fatty liver disease: implications for epidemiological studies. Gastroenterology 2003; 124:248-50.
14. NICE 2002/055. Type 2 diabetes - management of blood pressure and blood lipids, 2002. [http://www.nice.org.uk]
15. Lebovitz HE, Kreider M, Freed MI. Evaluation of liver function in type 2 diabetic patients during clinical trials. Diabetes Care 2002; 25:815-21.
16. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120:1183-92.
17. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002; 35:367-72.
18. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35:373-9.
19. Olsson R, Wesslan C, William-Olsson T, Zettergren L. Elevated aminotransferases and alkaline phosphatases in unstable diabetes mellitus without ketoacidosis or hypoglycaemia. J Clin Gastroenterol 1989; 11:541-5.
20. Munns CFJ, McCrossin RB, Thomsett MJ, Batch J. Hepatic glycogenosis: reversible hepatomegaly in type 1 diabetes. J Paediatr Child Health 2000; 36:449-52.